Liminatus Pharma, Inc. (LIMN)
3.78
+0.09
(+2.44%)
USD |
NASDAQ |
Oct 09, 16:00
3.78
0.00 (0.00%)
After-Hours: 20:00
Liminatus Pharma Price : 3.78 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 3.95 | 3.95 | 3.531 | 3.69 | 38562.00 |
| Oct 07, 2026 | 3.701 | 3.89 | 3.65 | 3.88 | 22936.00 |
| Oct 06, 2026 | 3.95 | 3.95 | 3.69 | 3.70 | 12631.00 |
| Oct 05, 2026 | 3.80 | 4.08 | 3.80 | 3.99 | 18090.00 |
| Oct 02, 2026 | 3.75 | 3.95 | 3.75 | 3.90 | 24332.00 |
| Oct 01, 2026 | 3.74 | 3.86 | 3.65 | 3.75 | 28172.00 |
| Sep 30, 2026 | 3.81 | 3.974 | 3.710 | 3.73 | 9264.00 |
| Sep 29, 2026 | 4.23 | 4.310 | 3.83 | 3.91 | 38362.00 |
| Sep 28, 2026 | 4.14 | 4.479 | 4.130 | 4.27 | 18548.00 |
| Sep 25, 2026 | 4.26 | 4.34 | 4.091 | 4.195 | 18579.00 |
| Sep 24, 2026 | 4.16 | 4.23 | 4.00 | 4.18 | 16970.00 |
| Sep 23, 2026 | 4.05 | 4.137 | 3.90 | 4.03 | 17701.00 |
| Sep 22, 2026 | 3.71 | 4.26 | 3.641 | 4.07 | 88496.00 |
| Sep 21, 2026 | 3.68 | 3.72 | 3.56 | 3.64 | 16137.00 |
| Sep 18, 2026 | 3.43 | 3.675 | 3.41 | 3.48 | 23256.00 |
| Sep 17, 2026 | 3.35 | 3.44 | 3.345 | 3.39 | 8874.00 |
| Sep 16, 2026 | 3.46 | 3.545 | 3.32 | 3.33 | 15696.00 |
| Sep 15, 2026 | 3.50 | 3.58 | 3.415 | 3.51 | 14257.00 |
| Sep 14, 2026 | 3.45 | 3.615 | 3.29 | 3.52 | 38007.00 |
| Sep 11, 2026 | 3.63 | 3.675 | 3.46 | 3.47 | 31463.00 |
| Sep 10, 2026 | 3.54 | 3.80 | 3.450 | 3.63 | 20175.00 |
| Sep 09, 2026 | 3.60 | 3.65 | 3.48 | 3.48 | 20836.00 |
| Sep 08, 2026 | 3.72 | 3.725 | 3.52 | 3.62 | 26298.00 |
| Sep 04, 2026 | 3.70 | 3.82 | 3.65 | 3.71 | 23256.00 |
| Sep 03, 2026 | 3.64 | 3.91 | 3.610 | 3.70 | 22527.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.52 |
| Anika Therapeutics, Inc. | 19.58 |
| Savara, Inc. | 4.925 |
| Vericel Corp. | 40.09 |
Price Related Metrics
| Price to Book Value | 0.2817 |
| Earnings Yield | -28.41K% |
| Market Cap | 0.0847M |